Siddharth Chachad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Siddharth Chachad has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Tausif Ahmed
Biopharmaceutics Group, Global Clinical Management, Dr. Reddy’s Laboratories Ltd., Integrated Product Development Organization (IPDO), Bachupally, Hyderabad, India
2 shared publications - Adithya Karthik Bhattiprolu
Biopharmaceutics Group, Global Clinical Management, Integrated Product Development Organization (IPDO), Dr. Reddy’s Laboratories Ltd, Bachupally, Medchal Malkajgiri District, Hyderabad, India
1 shared publication - Aditya Murthy
Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
1 shared publication - Rajkumar Boddu
Biopharmaceutics Group, Global Clinical Management, Dr. Reddy’s Laboratories Ltd., Integrated Product Development Organization (IPDO), Bachupally, Medchal Malkajgiri District, Hyderabad 500090, Telangana, India
1 shared publication - Richa Aishwarya
Department of Pathology and Translational Pathobiology, LSU Health Shreveport, Shreveport, USA
1 shared publication - Sivacharan Kollipara
Biopharmaceutics Group, Global Clinical Management, Dr. Reddy’s Laboratories Ltd, Integrated Product Development Organization (IPDO), Hyderabad, India
1 shared publication
Latest Publications
- 9 September 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (12) , 3397-3410
Utility of Physiologically Based Biopharmaceutics Modeling (PBBM) in Regulatory Perspective: Application to Supersede f2, Enabling Biowaivers & Creation of Dissolution Safe Space
- 9 September 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (12) , 3397-3410
Utility of Physiologically Based Biopharmaceutics Modeling (PBBM) in Regulatory Perspective: Application to Supersede f2, Enabling Biowaivers & Creation of Dissolution Safe Space
- 23 February 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (6) , 1820-1832
A Novel Approach to Justify Dissolution Differences in an Extended Release Drug Product using Physiologically Based Biopharmaceutics Modeling and Simulation
- 23 February 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (6) , 1820-1832
A Novel Approach to Justify Dissolution Differences in an Extended Release Drug Product using Physiologically Based Biopharmaceutics Modeling and Simulation